Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model

被引：0
|
作者：
Margarite D. Matossian
Hope E. Burks
Steven Elliott
Van T. Hoang
Annie C. Bowles
Rachel A. Sabol
Bahia Wahba
Muralidharan Anbalagan
Brian Rowan
Mohamed E. Abazeed
Bruce A. Bunnell
Krzysztof Moroz
Lucio Miele
Lyndsay V. Rhodes
Steven D. Jones
Elizabeth C. Martin
Bridgette M. Collins-Burow
Matthew E. Burow
机构：
[1] Tulane University School of Medicine,Department of Medicine, Section of Hematology & Medical Oncology
[2] Tulane University School of Medicine,Department of Pharmacology
[3] Tulane Center for Stem Cell Research and Regenerative Medicine,Department of Structural and Cellular Biology
[4] Tulane University,Department of Pathology
[5] Cleveland Clinic,Department of Surgery
[6] Department of Radiation Oncology,Department of Genetics and Stanley S. Scott Cancer Center
[7] Tulane Cancer Center,Department of Biology
[8] Tulane University School of Medicine,Department of Agricultural Engineering
[9] Tulane University School of Medicine,undefined
[10] Louisiana Cancer Research Center,undefined
[11] Biospecimen Core,undefined
[12] Louisiana State University Health Sciences Center,undefined
[13] Florida Gulf Coast University,undefined
[14] Louisiana State University,undefined
来源：
BMC Cancer | / 19卷
关键词：
Triple-negative breast cancer; Patient-derived xenograft; Mammosphere; Chemoresistance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model
    Matossian, Margarite D.
    Burks, Hope E.
    Elliott, Steven
    Hoang, Van T.
    Bowles, Annie C.
    Sabol, Rachel A.
    Wahba, Bahia
    Anbalagan, Muralidharan
    Rowan, Brian
    Abazeed, Mohamed E.
    Bunnell, Bruce A.
    Moroz, Krzysztof
    Miele, Lucio
    Rhodes, Lyndsay V.
    Jones, Steven D.
    Martin, Elizabeth C.
    Collins-Burow, Bridgette M.
    Burow, Matthew E.
    [J]. BMC CANCER, 2019, 19 (1)
  • [2] Application of triple negative breast cancer patient-derived organoid and xenograft model for drug screening
    Ryu, Seungyeon
    Kim, Hoe Suk
    Kim, Jung Eun
    Yoon, So-Hyun
    Lee, Sangeun
    Baek, Moonjou
    Lee, Han-Byoel
    Lee, Dong Woo
    Ku, Bosung
    Han, Wonshik
    [J]. CANCER RESEARCH, 2022, 82 (12)
  • [3] Utilizing a decellularized patient-derived xenograft tumor model for the evaluation of triple negative breast cancer
    Wright, Maryl
    Matossian, Margarite
    King, Connor
    Nguyen, Khoa
    Elliott, Steven
    Alzoubi, Madlin
    Martin, Elizabeth
    Collins-Burow, Bridgette
    Burow, Matthew
    [J]. CANCER RESEARCH, 2020, 80 (04)
  • [4] A novel patient-derived xenograft model for claudin-low triple-negative breast cancer
    Matossian, Margarite D.
    Burks, Hope E.
    Bowles, Annie C.
    Elliott, Steven
    Hoang, Van T.
    Sabol, Rachel A.
    Pashos, Nicholas C.
    O'Donnell, Benjamen
    Miller, Kristin S.
    Wahba, Bahia M.
    Bunnell, Bruce A.
    Moroz, Krzysztof
    Zea, Arnold H.
    Jones, Steven D.
    Ochoa, Augusto C.
    Al-Khami, Amir A.
    Hossain, Fokhrul
    Riker, Adam I.
    Rhodes, Lyndsay V.
    Martin, Elizabeth C.
    Miele, Lucio
    Burow, Matthew E.
    Collins-Burow, Bridgette M.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2018, 169 (02) : 381 - 390
  • [5] A novel patient-derived xenograft model for claudin-low triple-negative breast cancer
    Margarite D. Matossian
    Hope E. Burks
    Annie C. Bowles
    Steven Elliott
    Van T. Hoang
    Rachel A. Sabol
    Nicholas C. Pashos
    Benjamen O’Donnell
    Kristin S. Miller
    Bahia M. Wahba
    Bruce A. Bunnell
    Krzysztof Moroz
    Arnold H. Zea
    Steven D. Jones
    Augusto C. Ochoa
    Amir A. Al-Khami
    Fokhrul Hossain
    Adam I. Riker
    Lyndsay V. Rhodes
    Elizabeth C. Martin
    Lucio Miele
    Matthew E. Burow
    Bridgette M. Collins-Burow
    [J]. Breast Cancer Research and Treatment, 2018, 169 : 381 - 390
  • [6] Development of humanized patient-derived xenograft models for triple negative breast cancer.
    Her, Yujeong
    Son, Hye Yeon
    Kim, Ju Hee
    Heo, Woo Hang
    Quan, Mingji
    Li, Songbin
    Moon, Hyeong Gon
    [J]. CANCER RESEARCH, 2022, 82 (12)
  • [7] Identifying metastatic drivers in patient-derived xenograft models of triple negative breast cancer
    Powell, Emily
    Shao, Jiansu
    Picon, Hector M.
    Ge, Zhongqi
    Echeverria, Gloria V.
    Peoples, Michael
    Bristow, Christopher
    Cai, Shirong
    Tu, Yizheng
    McCoy, Aaron M.
    Piwnica-Worms, David
    Draetta, Giulio
    Edwards, John R.
    Moulder, Stacy L.
    Symmans, William F.
    Heffernan, Timothy P.
    Liang, Han
    Piwnica-Worms, Helen
    [J]. CANCER RESEARCH, 2018, 78 (04)
  • [8] Molecular characterization of a patient-derived xenograft (PDX) resource for triple negative breast cancer
    Graber, Joel H.
    Keck, James G.
    Airhart, Susan D.
    Bult, Carol J.
    Liu, Edison T.
    [J]. CANCER RESEARCH, 2015, 75
  • [9] Dinaciclib overcomes resistance to BKM120 in triple negative breast cancer patient-derived xenograft models
    Rajput, Sandeep
    Guo, Fang
    Shun, Li
    Ma, Cynthia
    [J]. CANCER RESEARCH, 2017, 77
  • [10] Pharmacologic profiling of patient-derived xenograft models of primary treatment-naive triple-negative breast cancer
    Powell, Reid T.
    Redwood, Abena
    Liu, Xuan
    Guo, Lei
    Cai, Shirong
    Zhou, Xinhui
    Tu, Yizheng
    Zhang, Xiaomei
    Qi, Yuan
    Jiang, Yan
    Echeverria, Gloria
    Feng, Ningping
    Ma, XiaoYan
    Giuliani, Virginia
    Marszalek, Joseph R.
    Heffernan, Timothy P.
    Vellano, Christopher P.
    White, Jason B.
    Stephan, Clifford
    Davies, Peter J.
    Moulder, Stacy
    Symmans, W. Fraser
    Chang, Jeffrey T.
    Piwnica-Worms, Helen
    [J]. SCIENTIFIC REPORTS, 2020, 10 (01)
12345